Clinical Trial Update: Tacrolimus Treatment for Refractory Autoimmune Cytopenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating tacrolimus for refractory autoimmune cytopenia, including autoimmune hemolytic anemia and pure red cell aplasia (Evan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia
• Evans Syndrome
• Pure Red Cell Aplasia

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Autoimmune Hemolytic Anemia, Pure Red Cell Aplasia | Phase 4 | Status: UNKNOWN